ACADIA Pharmaceuticals Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ACAD Nasdaq 2834 http://www.acadia-pharm.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ACADIA Pharmaceuticals Inc.

Analysts are Cutting Price Targets of These 10 Stocks - Oct 15th, 2021 12:25 pm
Acadia (ACAD) Down 10.8% Since Last Earnings Report: Can It Rebound? - Sep 3rd, 2021 3:31 pm
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences - Sep 2nd, 2021 1:00 pm
Acadia Pharmaceuticals Announces Executive Leadership Change - Sep 1st, 2021 8:05 pm
Stanley Druckenmiller is Loading Up on These 15 Stocks - Aug 26th, 2021 1:55 pm
ACADIA Pharmaceuticals (NASDAQ:ACAD shareholders incur further losses as stock declines 5.1% this week, taking one-year losses to 56% - Aug 22nd, 2021 12:04 pm
Acadia Pharmaceuticals Inc (ACAD) Q2 2021 Earnings Call Transcript - Aug 6th, 2021 8:31 pm
Lifshitz Law Firm, P.C. Announces Investigations of 3D Systems Corp. (NYSE: DDD), Acadia Pharmaceuticals, Inc. (NasdaqGS: ACAD), ChemoCentryx, Inc. (NasdaqGS: CCXI), and Peloton Interactive, Inc (NasdaqGS: PTON) - Aug 6th, 2021 5:54 pm
Acadia Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021 - Aug 5th, 2021 8:05 pm
ACADIA (ACAD) Q2 Earnings Beat, Revenues Miss Estimates - Aug 5th, 2021 4:53 pm
Acadia Pharmaceuticals (ACAD) Reports Q2 Loss, Misses Revenue Estimates - Aug 4th, 2021 9:25 pm
ACADIA: The Street’s Gaze Turns to FDA Meeting’s Outcome on DRP Treatment - Aug 3rd, 2021 11:30 pm
Analysts Estimate Acadia Pharmaceuticals (ACAD) to Report a Decline in Earnings: What to Look Out for - Jul 28th, 2021 7:03 pm
The New England Journal of Medicine Publishes Results from the Phase 3 HARMONY Study Evaluating Pimavanserin in Patients with Dementia-Related Psychosis - Jul 21st, 2021 9:05 pm
Acadia Pharmaceuticals to Announce Second Quarter 2021 Financial Results on August 4, 2021 - Jul 21st, 2021 1:00 pm
Synlogic's (SYBX) Begins Phase I Study for PKU Treatment - Jul 16th, 2021 3:22 pm
Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the Alzheimer’s Association International Conference 2021 (AAIC) - Jul 14th, 2021 1:00 pm
Hedge Funds Aren’t Crazy About ACADIA Pharmaceuticals Inc. (ACAD) Anymore - Jul 6th, 2021 3:37 pm
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Acadia Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 21, 2021 - ACAD - Jun 21st, 2021 9:02 pm
Today - Final Deadline for Investors With Losses Exceeding $100K to Actively Participate in ACADIA Pharmaceuticals Inc. (ACAD) Class Action: Bronstein, Gewirtz & Grossman, LLC - Jun 21st, 2021 7:33 pm